David Garcia Cinca: Clinical Trials

5 unknown, 1 completed, 1 not yet recruiting. 3 Phase 3, 2 Phase 2, 1 Not applicable, 1 Phase 4.

By phase and status

Phase	Trials	Status
Phase 3	3	Unknown 2, Completed 1
Phase 2	2	Not yet recruiting 1, Unknown 1
Not applicable	1	Unknown 1
Phase 4	1	Unknown 1

Follow David Garcia Cinca: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial) Pertuzumab and trastuzumab FDC subcutaneous, Paclitaxel, TDM1 - Mammary Cancer	Phase 2	Not yet recruiting	David Garcia Cinca	27	2020-06-15	2020-03-10
Progression of Damage in Ulcerative Colitis Magnetic Resonance Imaging - Ulcerative Colitis	Not applicable	Unknown	David Garcia Cinca	20	2019-06-15	2019-05-20
Effect of Cannabinoid (THC / CBD 50%) on Hyperalgesia in Patients With Deep Endometriosis Cannabinoid treatment - Endometriosis	Phase 2	Unknown	David Garcia Cinca	10	2019-04-01	2019-03-14
Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response Moxifloxacin, Placebo - Community-acquired Pneumonia	Phase 4	Unknown	David Garcia Cinca	424	2019-02-15	2019-12-05
Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-induced Nephropathy (CIN) in Patients With Renal Insufficiency (RI) Grade III Under Study Conducting Computed Tomography (CT) Oral hydratation, Bicarbonate endovenous hydratation, Saline endovenous hydratation - Renal Insufficiency	Phase 3	Completed	David Garcia Cinca	264	2017-07-04	2021-02-02
Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With Cirrhosis Rivaroxaban, Placebo - Cirrhosis	Phase 3	Unknown	David Garcia Cinca	160	2016-05-01	2018-04-25
Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection Antiretroviral Therapy (Experimental) - HIV Infections	Phase 3	Unknown	David Garcia Cinca	15	2016-04-01	2016-08-17

Conditions studied

Breast Neoplasms (1)  ·  Colitis, Ulcerative (1)  ·  Community-Acquired Pneumonia (1)  ·  Endometriosis (1)  ·  Fibrosis (1)  ·  HIV Infections (1)  ·  Renal Insufficiency (1)

Interventions

Magnetic Resonance Imaging (1)  ·  Moxifloxacin (1)  ·  Paclitaxel (1)  ·  Rivaroxaban (1)  ·  pertuzumab (1)

Countries

Spain (7)

Results publications

PMID 40691992

NIH funding

2014 (1), 2015 (1), 2018 (1), 2019 (1)